Genzyme to Acquire AstraZeneca Rare Disease Therapy

29.07.2015 - French pharmaceutical producer Sanofi and its subsidiary Genzyme have agreed to acquire the Caprelsa (vandetanib) rare disease therapy of British-Swedish drugmaker AstraZeneca...